Want to join the conversation?
$AMGN said the U.S. FDA accepted for priority review the supplemental Biologics License Application for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric and adolescent patients with Philadelphia chromosomeâ??negative (Ph-) relapsed or refractory B-cell precurs acute lymphoblastic leukemia.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.